U.S. Buys More Smallpox Vaccine

British drug maker Acambis has received a $30 million deal to supply 10 million new doses of its ACAM2000 smallpox vaccine for the U.S. Strategic National Stockpile, the company announced yesterday (see GSN, Sept. 6).

The Centers for Disease Control and Prevention ordered the doses under an existing supply contract, under which Acambis has already supplied 182.5 million doses.

Acambis plans to supply the doses from its existing inventory this year (Acambis release/Market Wire, Sept. 12).

Back to top
About Newswire  |  Contact National Journal  |  Re-Use Guidelines © Copyright 2008 by National Journal Group, Inc. The material in this section is produced independently for NTI by National Journal Group, Inc. Any reproduction or retransmission, in whole or in part, is a violation of federal law and is strictly prohibited without the consent of the National Journal Group, Inc. All rights reserved.